We are live on ! Find out more
HL

Harding Loevner Portfolio holdings

AUM $10.6B
1-Year Est. Return 19.39%
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+19.39%
3 Year Est. Return
+79.14%
5 Year Est. Return
+100.61%
10 Year Est. Return
+428.16%
AUM
$11.4B
AUM Growth
-$2.27B
Cap. Flow
-$2.48B
Cap. Flow %
-21.8%
Top 10 Hldgs %
47.15%
Holding
79
New
8
Increased
13
Reduced
55
Closed
3

Top Buys

Rank Stock Value
1
VEU icon
Vanguard FTSE All-World ex-US ETF
VEU
+$78.4M
2
EFX icon
Equifax
EFX
+$70.4M
3
FN icon
Fabrinet
FN
+$60.8M
4
NICE icon
Nice
NICE
+$44.1M
5
HON icon
Honeywell
HON
+$30.6M

Top Sells

Rank Stock Value
1
SAP icon
SAP
SAP
+$488M
2
BHP icon
BHP
BHP
+$440M
3
LIN icon
Linde
LIN
+$397M
4
TSM icon
TSMC
TSM
+$242M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$134M

Sector Composition

Rank Sector Weight
1 Technology 28.45%
2 Financials 19.27%
3 Healthcare 11.58%
4 Communication Services 10.36%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
26
CME Group
CME
$101B
$162M 1.43%
593,278
-97,149
-14% -$26.4M
NVDA icon
27
NVIDIA
NVDA
$5.56T
$160M 1.41%
859,326
-118,012
-12% -$22M
VEU icon
28
Vanguard FTSE All-World ex-US ETF
VEU
$71.3B
$141M 1.24%
1,918,731
+1,077,833
+128% +$78.4M
AVGO icon
29
Broadcom
AVGO
$1.7T
$136M 1.2%
393,763
-57,535
-13% -$20.6M
PGR icon
30
Progressive
PGR
$127B
$134M 1.18%
587,141
-104,237
-15% -$23.5M
APH icon
31
Amphenol
APH
$204B
$129M 1.13%
1,908,718
-595,110
-24% -$39.8M
TW icon
32
Tradeweb Markets
TW
$22.4B
$121M 1.06%
1,121,185
-182,491
-14% -$19.6M
ADBE icon
33
Adobe
ADBE
$106B
$115M 1.01%
328,484
+27,315
+9% +$9.29M
ACN icon
34
Accenture
ACN
$114B
$110M 0.97%
409,515
-61,002
-13% -$15.5M
GMAB icon
35
Genmab
GMAB
$20.7B
$104M 0.91%
3,370,143
-114,344
-3% -$3.56M
TLK icon
36
Telkom Indonesia
TLK
$14.6B
$94.2M 0.83%
4,476,641
-448,637
-9% -$9.16M
SAP icon
37
SAP
SAP
$248B
$94M 0.83%
386,893
-1,913,444
-83% -$488M
HEI icon
38
HEICO Corp
HEI
$45.5B
$92M 0.81%
284,395
-44,158
-13% -$14M
AME icon
39
Ametek
AME
$54.5B
$86.6M 0.76%
421,690
-8,266
-2% -$1.61M
HON icon
40
Honeywell
HON
$66.4B
$85.5M 0.75%
438,098
+156,622
+56% +$30.6M
ABBV icon
41
AbbVie
ABBV
$453B
$84.7M 0.75%
370,833
-59,661
-14% -$13.6M
TMO icon
42
Thermo Fisher Scientific
TMO
$227B
$84M 0.74%
145,025
-23,551
-14% -$13.3M
V icon
43
Visa
V
$700B
$84M 0.74%
239,587
+35,643
+17% +$12.1M
NVS icon
44
Novartis
NVS
$304B
$83.2M 0.73%
603,387
-26,571
-4% -$3.48M
DHR icon
45
Danaher
DHR
$146B
$82.6M 0.73%
360,923
-54,733
-13% -$12M
ELV icon
46
Elevance Health
ELV
$88.4B
$77.4M 0.68%
220,725
-25,640
-10% -$8.66M
JNJ icon
47
Johnson & Johnson
JNJ
$663B
$75.5M 0.66%
365,029
-59,731
-14% -$11.8M
SLB icon
48
SLB Ltd
SLB
$85.3B
$71M 0.62%
1,850,343
-115,565
-6% -$4.19M
EFX icon
49
Equifax
EFX
$20.8B
$69.7M 0.61%
+321,343
New +$70.4M
DE icon
50
Deere & Co
DE
$187B
$66.3M 0.58%
142,343
-182,376
-56% -$85.6M

Similar funds

Harding Loevner's Q4 2025 Portfolio in Review

As of Q4 2025, Harding Loevner held 79 positions worth $11.4B, down 17% from $13.6B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Harding Loevner withdrew a net $2.48B in Q4 2025, closing 3 positions and reducing 55 holdings. Its most notable exit was Synopsys, an estimated $119M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Harding Loevner opened a new position in Equifax worth $69.7M.

  • Harding Loevner's largest Q4 2025 buy was Equifax: 321,343 shares worth $69.7M.
  • Harding Loevner added most to Vanguard FTSE All-World ex-US ETF in Q4 2025, an estimated $78.4M increase.
  • Harding Loevner's biggest Q4 2025 reduction was SAP, cutting an estimated $488M.
  • Harding Loevner fully exited Synopsys in Q4 2025, selling an estimated $119M.
  • Harding Loevner's ten largest holdings make up 47% of its $11.4B portfolio in Q4 2025.
  • Harding Loevner opened 8 new positions and closed 3 in Q4 2025.
  • Harding Loevner's portfolio value fell 17% quarter-over-quarter to $11.4B.

Based on Harding Loevner's 13F filing for Q4 2025, filed 17 Feb 2026.